BioSig Technologies, Inc. (BSGM)
| Market Cap | 42.00M |
| Revenue (ttm) | 159,000 |
| Net Income (ttm) | -28.87M |
| Shares Out | 56.76M |
| EPS (ttm) | -0.75 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 163,084 |
| Open | 0.780 |
| Previous Close | 0.770 |
| Day's Range | 0.710 - 0.790 |
| 52-Week Range | 0.251 - 1.910 |
| Beta | 1.23 |
| Analysts | Buy |
| Price Target | 3.83 (+417.57%) |
| Earnings Date | Feb 13, 2023 |
About BSGM
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for BSGM stock is "Buy." The 12-month stock price forecast is $3.83, which is an increase of 417.57% from the latest price.
News
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology
Westport, CT, Jan. 10, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented a...
Update: BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Hear...
BioSig's PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Hear...
BioSig's PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology
Clinical abstract focuses on value of PURE EP™'s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation Clinical abstract focuses on value of PURE EP™'s and its groundbr...
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
Westport, CT, Oct. 24, 2022 (GLOBE NEWSWIRE) --
BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022
Company to introduce its novel digital signal processing technology to the European EP community at world-renown international congress Company to introduce its novel digital signal processing technol...
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base
Leading medical center in San Antonio acquires BioSig's novel digital signal processing technology for arrhythmia care Leading medical center in San Antonio acquires BioSig's novel digital signal proc...
BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module
Company to introduce the most advanced iteration of its signal processing technology at Cleveland Clinic's Global EP Summit 2022, a world-class leadership symposium Company to introduce the most advan...
Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 400 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
(BSGM), (OPFI) – 3 Stocks Under $3 Insiders Are Buying
The Dow Jones closed lower by more than 300 points on Friday. Investors, meanwhile, focused on some notable insider trades.
(BSGM), (LDI) – BioSig Technologies, Reliance Global Group And 2 Other Penny Stocks Insiders Are Aggressively Buying
U.S. stocks recorded losses for the fourth straight session on Wednesday. Investors, meanwhile, focused on some notable insider trades.
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth
Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gr...
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence
Westport, CT, Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gr...
BioSig's Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022
Leading Medical Center of Excellence Physician will discuss integrating the PURE EP™ System into their practice and procedural workflow Leading Medical Center of Excellence Physician will discuss inte...
BioSig Sees Positive Momentum from Sales Pipeline Growth
Westport, CT, Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gr...
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute
Led by Dhanunjaya DJ Lakkireddy, MD., the study will investigate expanded applications for the signals acquired by BioSig's PURE EP(T.M.) System Led by Dhanunjaya DJ Lakkireddy, MD., the study will in...
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center
Westport, CT, July 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gr...
BioSig Announces Closing of Public Offering of Common Stock
Westport, CT, June 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering gre...
BioSig Announces Pricing of Public Offering of Common Stock
Westport, CT, June 24, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering gre...
BioSig Announces Proposed Public Offering of Common Stock
Westport, CT, June 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal proce...
BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide
Westport, CT, May 26, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering gre...
BioSig's PURE EP™ System to be Featured During EPLive 2022
The Company's flagship technology to be featured during a two-day educational conference that draws the world's top cardiac electrophysiology experts The Company's flagship technology to be featured d...
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering gre...
BioSig to Present at Heart Rhythm 2022
Company's conference program to include physician presentations and technology demonstrations, including features of its newly released PURE EP(TM) Nova-5 Software Company's conference program to incl...
BioSig to Present at NobleCon18 Capital Markets Conference
Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing plat...